 | • レポートコード：B-MOR-040823 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥569,800 (USD3,850) | ▷ お問い合わせ |
| Team User（7名様用） | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Corporate User | ￥1,221,000 (USD8,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
Wound care is performed by nurses under the physician’s orders for many of the injuries caused to the patients. There are a wide range of wounds, such as surgical, pressure or decubitus ulcer, venous stasis ulcer, arterial ulcer, diabetic ulcer, and traumatic. The Europe wound management market is expected to register a CAGR of 3.6% during 2018-2023 (the forecast period).
Increasing Incidences of Chronic Wounds
A wound is one of the major health issues prevailing in Europe. The population prevalence of chronic wounds is 3-4/1000 people, which roughly translates to be between 1.5-2.0 million of the 491 million inhabitants of the EU. Annual incidence estimate for, both, acute and chronic wounds stands at 4 million in the region. It has been estimated that there is a prevalence of about 1-1.4 million diabetic foot ulcers (DFUs) and 0.5-1.3 million leg ulcers in Europe, along with 400,000-600,000 new DFUs and almost one million new venous leg ulcers (VLUs), per year. Wound care has become a major concern for patients suffering from diabetes, due to the slow healing process.
The growing demand for faster recovery of wounds, increase in the number of surgeries, and growing aging population are some other factors driving the market.
High Cost Procedures
An increase in the value and prices has always affected a market. In the WCM domain, the expenditure involved in some therapies can exceed USD 200,000. Most of the healthcare insurance providers do not cover wound care treatment costs and even if they do, the percentage covered is quite low. Due to the low-reimbursement rates, patients are unable to afford advanced wound care treatments. This factor decelerates the total revenue generated by the market. The cost for general treatments is affordable, however, the ones that involve special care have significant costs associated with them. Moreover, the development of affordable solutions is expected to drive the market growth.
The lack of proper reimbursements and reluctance in acceptance of new technologies are some other factors restraining the market growth.
Germany to Dominate the Market
The wound Management market has been segmented on the basis of product, wound healing therapy, and geography. By geography, the market has been segmented into France, Germany, United Kingdom, Italy, Spain, and Rest of Europe.
Owing to the factors, like increasing research activities in the field of wound care and rising governmental investment for wound care research, Germany dominates the Europe wound management market.
Major Players: J&J, BIOTRONIK, BOSTON SCIENTIFIC, ST JUDE MEDICAL, MEDTRONIC/COVIDIEN, ZOLL MEDICAL CORPORATION, CARDIA SCIENCE, LIVANOVA, SCHILLER AG, NIHON KOHDEN CORPORATION, MOLNLYCKE HEALTH CARE amongst others.
Reasons to Purchase this Report
• Market analysis for the Europe wound management market, with region-specific assessments and competition analysis on the regional scale.
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• The regions that are expected to witness the fastest growth during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Demand For Faster Recovery of Wounds
6.1.2 Increasing Incidences of Chronic Wound
6.1.3 Growth in Aging Population
6.2 Market Restraints
6.2.1 High Cost Procedures
6.2.2 Lack of Proper Reimbursements
6.2.3 Reluctance In Acceptance of New Technologies
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Advanced Wound Dressing
7.1.1.1 Foam Dressing
7.1.1.2 Hydrocolloid Dressing
7.1.1.3 Film Dressing
7.1.1.4 Alginate Dressing
7.1.1.5 Hydrogel Dressing
7.1.1.6 Other Advanced Dressing
7.1.2 Wound Therapy Devices
7.1.2.1 Pressure Relief Devices
7.1.2.2 Negative Pressure Wound Therapy (NPWT) Systems
7.1.2.3 Oxygen And Hyperbaric Oxygen Equipment
7.1.2.4 Electrical Stimulation Devices
7.1.2.5 Other Therapy Devices
7.1.3 Active Wound Care Products
7.1.4 Surgical Wound Care Products
7.1.4.1 Sutures And Staples
7.1.4.2 Tissue Adhesives, Sealants, & Glues
7.2 By Wound Healing Therapy
7.2.1 Collagen
7.2.2 Biological Dressing
7.2.3 Biological Skin Equivalents (BSE)
7.2.4 Keratinocytes
7.2.5 Platelet-derived Wound Healing
7.2.6 Platelet Rich Plasma
7.2.7 Silver
7.2.8 Intermittent Pneumatic Compression Therapy
7.2.9 Negative Pressure Wound Therapy (NPWT)
7.2.10 Electromagnetic Therapy (EMT)
7.2.11 Hyperbaric Oxygen Therapy (HBOT)
7.2.12 Topical Oxygen Therapy (TOT)
7.2.13 Ozone Oxygen Therapy
7.3 By Type of Wound
7.3.1 Chronic Wound
7.3.2 Acute Wound
7.4 By End User
7.4.1 Hospitals And Specialty Wound Clinics
7.4.2 Long-Term Care Facilities
7.5 By Geography
7.5.1 Europe
7.5.1.1 France
7.5.1.2 UK
7.5.1.3 Germany
7.5.1.4 Italy
7.5.1.5 Spain
7.5.1.6 Rest of Europe
8. Competitive Landscape
8.1 Mergers and Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 J&J
9.2 St Jude Medical
9.3 Medtronic/Covidien
9.4 Cardiac Science
9.5 Livanova
9.6 Schiller Ag
9.7 Nihon Kohden Corporation
9.8 Molnlycke Health Care
10. Future of the Market